Vanguard Global Advisers’s Merck MRK Stock Holding History

Vanguard Global Advisers’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$708M	Sell	5,512,538 -73,156	-1%	-$8.56M	0.33%	48
2026 Q1	$672M	Buy	+5,585,694	New	+$645M	0.36%	43

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Vanguard Global Advisers's MRK Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Merck (MRK) stake by 1.3% in Q2 2026, selling an estimated $8.56M and leaving 5,512,538 shares worth $708M. The position accounts for 0.33% of the portfolio, ranked #48.

Vanguard Global Advisers first reported a position in MRK in Q1 2026 and has held it in 2 quarters since. 3,688 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Vanguard Global Advisers held 5,512,538 shares of Merck worth $708M as of Q2 2026.
Vanguard Global Advisers sold 73,156 Merck shares in Q2 2026, an estimated $8.56M.
Merck made up 0.33% of Vanguard Global Advisers's portfolio in Q2 2026, its #48 holding.
Vanguard Global Advisers first reported a position in Merck in Q1 2026 and has held it in 2 quarters since.
3,688 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.